BIO vs HYPD · rev $2.58B vs rev $57.3K
BIO (BIO) versus Hyperion DeFi, Inc. (HYPD) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Hyperion DeFi, Inc. (HYPD) is a biotechnology company listed on NASDAQ.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported HYPD revenue for 2024-12-31 was $57.3K. Net income was -$49.8M. Revenue was up 1414.0% from 2023-12-31 to 2024-12-31. HYPD currently screens at market cap $48.5M.
BIO currently screens at market cap $0. HYPD currently screens at market cap $48.5M.
Not investment advice. Open the BIO and HYPD stock pages for the full models.
Not investment advice.